DNER and acute myeloid leukemia: Winter et al. created a bifunctional JQ1 molecule fused with thalidomide, called dBET which can specifically target BET protein for E3 ligase mediated degradation, resulting in a higher level of apoptosis in primary AML cells than those treated with JQ1 alone (Winter et al., 2015).